$131.82
0.87% yesterday
Nasdaq, Jun 27, 10:15 pm CET
ISIN
US44930G1076
Symbol
ICUI

ICU Medical, Inc. Target price 2025 - Analyst rating & recommendation

ICU Medical, Inc. Classifications & Recommendation:

Buy
82%
Hold
18%

ICU Medical, Inc. Price Target

Target Price $192.78
Price $131.82
Potential
Number of Estimates 6
6 Analysts have issued a price target ICU Medical, Inc. 2026 . The average ICU Medical, Inc. target price is $192.78. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 9 Analysts recommend ICU Medical, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2026 of . Most analysts recommend the ICU Medical, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.38 2.25
5.44% 5.59%
EBITDA Margin 4.36% 17.53%
51.41% 301.67%
Net Margin -4.94% 7.41%
276.32% 249.98%

8 Analysts have issued a sales forecast ICU Medical, Inc. 2025 . The average ICU Medical, Inc. sales estimate is

$2.2b
Unlock
. This is
7.07% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.4b 1.45%
Unlock
, the lowest is
$2.1b 12.07%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.4b 5.44%
2025
$2.2b 5.59%
Unlock
2026
$2.2b 0.71%
Unlock
2027
$2.4b 5.60%
Unlock
2028
$2.6b 10.73%
Unlock
2029
$2.7b 3.49%
Unlock

8 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2025. The average ICU Medical, Inc. EBITDA estimate is

$394m
Unlock
. This is
207.90% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$425m 232.15%
Unlock
, the lowest is
$373m 191.63%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $104m 59.64%
2025
$394m 279.19%
Unlock
2026
$444m 12.58%
Unlock
2027
$491m 10.59%
Unlock
2028
$617m 25.61%
Unlock
2029
$659m 6.97%
Unlock

EBITDA Margin

2024 4.36% 51.41%
2025
17.53% 301.67%
Unlock
2026
19.87% 13.35%
Unlock
2027
20.82% 4.78%
Unlock
2028
23.61% 13.40%
Unlock
2029
24.41% 3.39%
Unlock

8 ICU Medical, Inc. Analysts have issued a net profit forecast 2025. The average ICU Medical, Inc. net profit estimate is

$167m
Unlock
. This is
277.82% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$174m 285.62%
Unlock
, the lowest is
$158m 268.61%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-118m 296.80%
2025
$167m 241.56%
Unlock
2026
$205m 23.22%
Unlock
2027
$238m 15.88%
Unlock
2028
$304m 27.89%
Unlock
2029
$333m 9.41%
Unlock

Net Margin

2024 -4.94% 276.32%
2025
7.41% 249.98%
Unlock
2026
9.19% 24.02%
Unlock
2027
10.09% 9.79%
Unlock
2028
11.65% 15.46%
Unlock
2029
12.32% 5.75%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -4.83 6.77
292.68% 240.17%
P/E 19.47
EV/Sales 2.00

8 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is

$6.77
Unlock
. This is
276.76% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$7.07 284.60%
Unlock
, the lowest is
$6.42 267.62%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-4.83 292.68%
2025
$6.77 240.17%
Unlock
2026
$8.34 23.19%
Unlock
2027
$9.67 15.95%
Unlock
2028
$12.36 27.82%
Unlock
2029
$13.53 9.47%
Unlock

P/E ratio

Current -34.42 27.37%
2025
19.47 156.57%
Unlock
2026
15.80 18.85%
Unlock
2027
13.64 13.67%
Unlock
2028
10.66 21.85%
Unlock
2029
9.75 8.54%
Unlock

Based on analysts' sales estimates for 2025, the ICU Medical, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.86 0.00%
2025
2.00 7.44%
Unlock
2026
2.01 0.72%
Unlock
2027
1.91 5.30%
Unlock
2028
1.72 9.69%
Unlock
2029
1.66 3.37%
Unlock

P/S ratio

Current 1.34 6.97%
2025
1.44 7.61%
Unlock
2026
1.45 0.71%
Unlock
2027
1.38 5.30%
Unlock
2028
1.24 9.69%
Unlock
2029
1.20 3.37%
Unlock

Current ICU Medical, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Raymond James
Locked
Locked
Locked May 09 2025
Keybanc
Locked
Locked
Locked Apr 21 2025
Needham
Locked
Locked
Locked Apr 08 2025
Jefferies
Locked
Locked
Locked Dec 11 2024
Keybanc
Locked
Locked
Locked Nov 13 2024
Needham
Locked
Locked
Locked Nov 13 2024
Keybanc
Locked
Locked
Locked Oct 15 2024
Analyst Rating Date
Locked
Raymond James:
Locked
Locked
May 09 2025
Locked
Keybanc:
Locked
Locked
Apr 21 2025
Locked
Needham:
Locked
Locked
Apr 08 2025
Locked
Jefferies:
Locked
Locked
Dec 11 2024
Locked
Keybanc:
Locked
Locked
Nov 13 2024
Locked
Needham:
Locked
Locked
Nov 13 2024
Locked
Keybanc:
Locked
Locked
Oct 15 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today